Elegan C

Services

Technical R&D Strategy

  1. Molecule-to-Mechanism Dossiers:  Comprehensive structural elucidation (NMR/MS) and biological screening for natural products.

  2. Neuroprotective Modelling: Specialised C. elegans Alzheimer’s (AD) model screening to validate cognitive health claims.

  3. NAMs & Regulatory Alignment: Navigating the FDA Modernisation Act 2.0 using animal-free, high-throughput methodologies.

Strategic Finance & Advisory

  1. International Capital Strategy: Leveraging expertise in Swiss investment and global asset management to structure R&D for institutional investment.

  2. Valuation & Due Diligence: Rigorous financial modeling of biotech assets for M&A, licensing, and partnership deals.

  3. Fractional CFO Support: Milestone-based budgeting, burn-rate optimization, and board- ready fiscal reporting.